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a b s t r a c t
Pharmaceutical products are often present in wastewater treatment effluents, rivers, lakes and, more
rarely, in groundwater. The advanced oxidation methods, like ultrasound, find a promising future in
the area of wastewater treatment. The aim of this paper is to evaluate the influence of several parameters
of the ultrasound process on the degradation of paracetamol, a widely used non-steroidal anti-inflamma-
tory recalcitrant drug found in water and levodopa, the most frequently prescribed drug for the treatment
of Parkinson disease. Experiments were carried out at 574, 860 and 1134 kHz of ultrasonic frequency
with horn-type sonicator and actual power values of 9, 17, 22 and 32W at 20 °C. Initial concentrations
of 25, 50, 100 and 150 mg Lÿ1 of both products were used. Treatment efficiency was assessed following
changes in pharmaceuticals concentration and chemical oxygen demand.
The sonochemical degradation of both products follows a pseudo-first-order reaction kinetics. Com-
plete removal of pharmaceuticals was achieved in some cases but some dissolved organic carbon remains
in solution showing that long lived intermediates were recalcitrant to ultrasound irradiation. Pollutants
conversion and COD removal were found to decrease with increasing the initial solute concentration and
decreasing power. The best results were obtained with 574 kHz frequency. Investigations using 1-butanol
as radical scavenger and H2O2 as promoter revealed that pollutants degradation proceeds principally
through radical reactions, although some differences were observed between both molecules. Addition
of H2O2 had a positive effect on degradation rate, but the optimum concentration of hydrogen peroxide
depends on the pollutant.
1. Introduction
The presence of drugs in waterways has been established for al-
most 30 years. However, there were few attempts to evaluate the
occurrence, fate and effects of pharmaceutical residues on the
environment until fairly recently, when more intensive efforts
began to be made. A wide variety of drugs have been found in
waterways of many countries, including analgesics, antibiotics,
antiepileptics, b-blockers and lipid regulators [44,31,32,39,26,36].
Most drugs are designed so that they retain their chemical
structure long enough to exert their therapeutic effect. This prop-
erty, combined with their continuous input, may enable them to
remain in the environment for extended periods of time. The pos-
sibility for continuous but undetectable or unnoticed effects of
pharmaceuticals on aquatic organisms is particularly worrisome
because the effects could accumulate so slowly that major change
goes undetected until the cumulative level of these effects finally
cascades to irreversible change [38].
Several research works have shown that many pharmaceuticals
are not completely removed during wastewater treatment and, as
a result, they are present in wastewater treatment plant effluents,
rivers and lakes, and more rarely in groundwater [44,19].
Considering the potential impacts of pharmaceutical products,
it is highly important to remove them from wastewater before dis-
charge. Alternative treatment technologies have to be considered.
In recent years, considerable interest has been shown in the appli-
cation of advanced oxidation processes for the treatment of phar-
maceutical contaminants in water. Examples of these studies are
the use of ozonation for the treatment of progesterone and amox-
icillin [5,1], the study of photocatalytic degradation of carbamaze-
pine, clofibric acid, iomeprol and iopromide [8,9], the use of Fenton
oxidation to improve the biodegradability of a real pharmaceutical
wastewater [37] and the paracetamol, diclofenac and clofibric acid
oxidation by means of ozonation and H2O2 photolysis [2,3,45].
On the other hand, ultrasound has increasing potential use in
the treatment of water, wastewater and sewage sludge. The
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sonochemical destruction of pollutants in aqueous phase generally
occurs as the result of imploding cavitation bubbles and involves
several reaction pathways such as pyrolysis inside the bubble
and hydroxyl radical-mediated reactions at the bubble–liquid
interface and/or in the liquid bulk [40]. The process was found to
be effective for the removal of several target chemical compounds
like phenol, chlorophenols, nitrophenols, polychlorinated biphe-
nyls, chloroaromatics, pesticides, dyes, CFCs, polycyclic aromatic
hydrocarbons and surfactants from relatively dilute (typically in
the micro- to milli-molar range) solutions [20,43]. However, it is
notable that only few studies have reported the use of ultrasound
for the removal of pharmaceutical products which are typically
found in waterways, as for the ibuprofen, diclofenac and some
endocrine disrupting compounds oxidation [27,15,7,11].
Levodopa is the most frequently prescribed drug for the treat-
ment of Parkinson disease [23] and although its occurrence in
the environment was not reported yet, it has been identified in
the effluents of a formulation plant in Cuba [35]. Levodopa effects
on the cellular death by oxidative stress and its neurotoxicity on
animals have been demonstrated [28]. On the other hand, paracet-
amol is one of the most frequently detected pharmaceutical prod-
ucts and its transformation into toxic compounds during
chlorination in wastewater treatment plants is well described by
Bedner and Maccrehan [6] .
The purpose of the present work was to examine the sonochem-
ical degradation of model aqueous solutions of levodopa and para-
cetamol and to investigate the effects of various operating
conditions on removal efficiency.
2. Experimental section
2.1. Chemicals
Levodopa and paracetamol for synthesis (Sigma–Aldrich) con-
taining more than 99% of pure compounds were used for the prep-
aration of solutions. Structural formula and solubility in water of
both compounds are shown in Table 1. Acetonitrile (Merck) was
HPLC quality, while orthophosphoric acid (85% purity) was pur-
chased from Fluka. Ultrapure water, used for sample preparation,
was obtained in a water purification system PURELAB Option
(ELGA).
2.2. Sonochemical degradation experiments
An ultrasound multifrequency generator (MEINHARDT
ULTRASCHALLTECHNIK) connected to a stainless steel-made trans-
ducer (E 805/T/M), operating in continuous mode at frequencies of
574, 860 and 1134 kHz and at variable electric power output, was
used for the sonication experiments. Reactions were carried out in
a 0.5 L cylindrical glass reaction vessel. Cooling of the reaction mix-
ture was achieved by circulating water, so as to maintain an aver-
age temperature of 20 ± 2 °C. In all cases, 300 mL of the aqueous
solution at initial concentrations of 25, 50, 100 and 150 mg Lÿ1
were prepared and subjected to ultrasonic irradiation. The sam-
ples, periodically withdrawn from the reactor, were analyzed
according to the procedures described below. The experimental
set-up is depicted in Fig. 1.
2.3. Calorimetry
Thompson and Doraiswamy [40] pointed out the importance of
reporting the acoustic power dissipated in the reaction systems for
subsequent researchers to reproduce results or compare reaction
conditions. In order to verify the actual ultrasonic power, the en-
ergy dissipated in the solution was determined by calorimetry
[30,21], the results are shown in Table 2.
2.4. High performance liquid chromatography (HPLC)
A fully computer controlled HPLC system UV/Vis Varian ProStar
310 involving a two solvents delivery pump Prostar 230, and an
autosampler Prostar 410 was used to follow the concentration-
time profiles of levodopa and paracetamol. Both products were
Table 1
Physical properties of levodopa and paracetamol.
Properties Levodopa Paracetamol
Structural formula
Solubility in water (gLÿ1) 1.65 (20 °C) 14 (20 °C)
log Pow ÿ2.9 0.89
Fig. 1. Experimental set-up: 1 –ultrasonic generator, 2 – transducer, 3 – glass
reactor, 4 – stirrer, 5 –thermostate, 6 – temperature measurement.
Table 2
Relationship between input and actual powers versus ultrasonic frequencies.
Frequency (kHz) Input power (W) Actual power (W)
1134 281 27
860 257 32
574 215 32
574 186 22
574 145 17
574 99 9
separated on a Prontosil column, 120-5-C18-AQ, 250 mm, 2 mm,
using 99:1 and 90:10 aqueous solutions of orthophosphoric acid
(pH 2.2):acetonitrile as an isocratic mobile phase respectively, at
0.25 mL minÿ1 flow rate and ambient temperature. The injection
volumes were 20 and 10 lL, respectively and detection was
achieved with the diode array detector set at 278 and 254 nm.
For quantification, the Varian Star Workstation chromatography
data handling software was used. Linearity between absorbance
and concentration was tested using external standards at various
concentrations and the response was found to be linear (with a
correlation coefficient r2 = 0.999 in both cases) over the whole
range of used concentrations. The dead time of the column was
2.6 min and the retention times of levodopa and paracetamol were
7 min and 6 min, respectively.
2.5. Chemical oxygen demand (COD)
The closed reflux colorimetric method was used to determine
COD values. Each time the appropriate amount of sample was
introduced into a commercially available digestion solution (Hach
Europe) and the mixture was then incubated for 120 min at 150 °C
in a COD reactor (Model DRB 200, Hach Company). COD concentra-
tion was measured colorimetrically using an Odyssey DR/2500
spectrophotometer (Hach Company).
3. Results and discussion
3.1. Effect of initial solute concentration
Fig. 2 shows the concentration–time profiles of levodopa and
paracetamol during their sonochemical degradation at 574 kHz,
20 °C, 32 W of actual power and initial solute concentrations of
25, 50, 100 and 150 mg Lÿ1. It should be pointed out that the per-
centage of degradation decreases with increasing initial concentra-
tion, but the amount of substrate destroyed increases with an
increase of initial concentration. 4 h sonication of a reaction mix-
ture initially containing 25, 50, 100 and 150 mg Lÿ1 of levodopa re-
sults in 91%, 70%, 54% and 46% of degradation respectively.
However, the amount of levodopa degraded at 150 mg Lÿ1 is as
much as about 2.8 times higher than that degraded at 25 mg Lÿ1.
For paracetamol, after 4 h of sonolysis, the extent of degradation
was 95%, 82%, 70% and 56%, for the reaction mixture initially con-
taining 25, 50, 100 and 150 mg Lÿ1 respectively, but the amount of
paracetamol degraded at 150 mg Lÿ1 is as much as about 3.6 times
greater than that degraded at 25 mg Lÿ1. Similar results have been
obtained by other authors with different products and the explana-
tion was that an increase in solute concentration would increase
the probability of hydroxyl radical attack on pollutant molecules
[4,25,42]. This behavior is characteristic of the OH chemistry at
the air-water interface of the bubbles [33]. Because at the interface
the steady-state OH concentration is very high and the OH–OH
recombination would be the dominant process, an increase of sub-
strate concentration would increase the fraction of OH that reacts
with the substrate, and the degradation rate would be increased as
a consequence. This fact is in accordance with the results obtained
in Section 3.4 and with the well fitting to the pseudo first-order
kinetics.
The degradation rate constants were determined assuming
pseudo first-order reaction kinetics as follows:
ÿ
dC
dt
¼ kC () ln
C0
C
¼ kt ð1Þ
where k is the pseudo first-order rate constant and C0 and C are the
product concentrations at time zero and t, respectively. If the results
of Fig. 2 are plotted in the form of Eq. (1), k values can be computed
from the slopes of the straight lines. These values are shown in
Table 3. Similar results have been obtained in previous studies by
Emery et al. [10] and Inoue et al. [17] where the sonochemical deg-
radation of various products was found to obey a pseudo first-order
reaction kinetics with k values decreasing when increasing initial
concentration. But, as previously explained, the initial reaction rate
(=k  C0) increases with substrate concentration. From Table 3, it is
clear that the degradation rate of paracetamol is always larger than
that of levodopa under the same sonication conditions and initial
concentrations. These results are consistent with the previously
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Fig. 2. Effect of initial concentration on sonochemical degradation of levodopa and paracetamol (frequency: 574 kHz, actual power: 32W, temperature: 20 °C). (j) 25 mg Lÿ1,
() 50 mg Lÿ1, (N)100 mg Lÿ1, (+) 150 mg Lÿ1, (–) calculated concentration from the pseudo first-order kinetic model.
Table 3
Pseudo first-order rate constants of pharmaceuticals degradations.
Concentration Levodopa Paracetamol
(mg Lÿ1) k(minÿ1) r2 k(minÿ1) r2
25 8.0  10ÿ3 0.98 1.25  10ÿ3 0.99
50 5.1  10ÿ3 0.99 7.1  10ÿ3 0.99
100 3.4  10ÿ3 0.99 5.4  10ÿ3 0.99
150 2.5  10ÿ3 0.98 3.6  10ÿ3 0.99
reported finding that the more hydrophobic the solute is, the more
effective its sonochemical degradation will be [18], hydrophobicity
being characterized by log POW (log of partition coefficient octanol/
water) as in Table 1.
Table 4 shows the substrate degradation and the COD removal
percentages after 8 h of ultrasonic irradiation. The negative effect
of an increase of pollutants initial concentration is evident on both
the degradation and the COD removal. Although a complete degra-
dation occurred in some cases, the conversion of all atoms of car-
bon to CO2 was never achieved. These results suggest that
organic carbon partially remains in the degradation products as re-
calcitrant organic acids. These results are in accordance with those
of other authors who, after a long time of ultrasonic irradiation, ob-
served only a small COD removal percentage. Inoue et al. [17] stud-
ied the sonochemical decomposition of Rhodamine B and Orange
II. The best COD removal percentages for both products, after
10 h of reaction, at 41.5 W, were: 37.3% and 37.6%, respectively.
Ku et al. [22] and Tiehm and Neis [41] studied other aromatic com-
pounds such as phenol and chlorophenol and also reveal a low COD
removal. These results show that the limiting step is the oxidation
of organic intermediate products. So, the complete mineralization
would be possible only with a much extended irradiation time
and with a very high ultrasonic supplied energy.
3.2. Influence of ultrasonic frequency
It is well known that the rate of sonochemical destruction for an
organic compound is frequency dependent. In addition, there is an
optimum frequency that may depend on the physical and chemical
properties of the organic compound.
In further experiments, the sonochemical degradation of levo-
dopa and paracetamol at an initial concentration of 25 mg Lÿ1,
20 °C and 574, 860 and 1134 kHz was investigated (see Fig. 3).
After 240 min of ultrasonic irradiation time, at frequencies of
574 kHz and 860 kHz, very similar results were obtained for both
products. A possible explanation for these results is that levodopa
and paracetamol oxidation takes place by reaction with OH radi-
cals and hydrogen peroxide. Petrier and Casadonte [29] in an inves-
tigation carried out at 20, 200, 500 and 800 kHz with transducers
having similar diameters and operating with the same power
(30W), demonstrated that the rates of hydrogen peroxide forma-
tion at 500 and 800 kHz are very similar. Although the collapse
of the cavity is rapid and more violent at higher frequencies, result-
ing in an increase in the magnitude of pressure generated at the
time of breakup and in an increased efficiency of the OH radical
production, it is well known that there is an optimum frequency
beyond which there are detrimental effects of frequency on the
degradation rates [16,12]. At very high frequencies, the cavitational
effect is reduced because either the rarefaction cycle of the sound
wave produces a negative pressure which is insufficient in its dura-
tion and/or intensity to initiate cavitation or the compression cycle
occurs faster than the time required for the microbubble to col-
lapse [40]. In our case, although the results at 574 and 860 kHz
are very similar, it is important to remember that lower frequen-
cies are preferred due to the associated drawbacks of the high fre-
quency operation. Frequencies below 574 kHz were not probed
due to the limits of the equipment frequency range.
On the other hand, the ultrasonic frequency of 1134 kHz
showed the lowest extent of degradation for both products. The ef-
fects of high frequency ultrasound in the megahertz range on the
degradation of organic pollutants and sonochemical mechanisms
are not clear because they are rarely studied [14]. Lifka et al. [24]
affirm that at frequencies above 1 MHz, the degradation rate of
low and high-volatile compounds decreases, but Hao et al. [14]
have demonstrated that products like 4-chlorophenol are decom-
posed under high temperature pyrolysis at 1.7 MHz. It is necessary
to notice that in this work, comparison of the results at 1134 KHz
with those obtained at 574 and 860 KHz frequencies is difficult be-
cause the actual power dissipated in the reactor is not exactly the
same (see Table 2).
3.3. Influence of ultrasonic power
In order to evaluate the influence of ultrasonic power on levo-
dopa and paracetamol degradation, the frequency of 574 kHz was
selected, and actual powers of 9, 17, 22 and 32W were tested. As
showed in Fig. 4, above a threshold power of about 9 W, the initial
degradation rates increase linearly with the actual power for both
products (with correlation coefficients of 0.9939 for levodopa and
0.9967 for paracetamol). This result is expected because, by
increasing the magnitude of power dissipation of the horn, there
will be an increase in the number of cavities generated and hence
the cumulative pressure pulse (number of cavities multiplied by
the collapse pressure due to a single cavity) will also increase. It
is important to note that, although in this work the initial degrada-
tion rates increase linearly with the actual power for both prod-
ucts, it does not mean that this increase will be unbounded. It is
well known that the enhancement of sonochemical effects with
increasing power dissipation in the system is only obtained until
an optimum power value, beyond which the rates of degradation
decrease with increased power input.
Table 4
Degradation and mineralization percentages after 8 h ultrasonic irradiation (frequency: 574 kHz, actual power: 32 W, temperature: 20 °C).
Initial concentration
(mg Lÿ1)
Levodopa Paracetamol
Degradation (%) Mineralization (%) Degradation (%) Mineralization (%)
25 100 31 100 39
50 97 26 98 33
100 80 17 96 27
150 61 13 73 18
Fig. 3. Influence of ultrasonic frequency on levodopa and paracetamol degradation
after 240 min of sonolysis (actual power: 32 W for 574 and 860 kHz and 27 W for
1134 kHz, pollutant initial concentration: 25 mg Lÿ1, temperature: 20 oC).
3.4. Sonochemical degradation in the presence of radical scavengers or
promoter
Sonolysis of organic compounds may occur by different mecha-
nisms. Compounds may be degraded via thermal decomposition
inside the bubble and/or in the interface, or by reactions with hy-
droxyl radicals and hydrogen peroxide at the interface and/or in
the bulk liquid. The relative importance of these mechanisms de-
pends on different factors such as the nature of the organic com-
pounds, the ultrasonic frequency, and the presence of gases in
the system, among others [42]. In our case, because both molecules
are non volatile, the solutes do not pyrolyze in the cavitation
bubbles.
It is possible to obtain information about the mechanism and
the zones in which sonochemical reactions take place by adding
radical scavengers to the system. When degradation rates of target
contaminants are considerably reduced in the presence of scaveng-
ers, free radical chain reactions are involved. Alcohols such as 1-
butanol are known to be effective OH radical scavengers for the
gaseous region and/or interfacial region of the collapsing bubble
[25]. A known scavenger for the liquid region is potassium bro-
mide, a non volatile strong electrolyte that can be readily oxidized
by free radicals.
Degradation experiments of levodopa and paracetamol have
been carried out in the presence of 1-butanol (22-fold molar con-
centration of 1-butanol to levodopa and paracetamol). The results
are shown in Fig. 5. As it can be seen, the addition of 1-butanol in
the reaction mixture inhibits both products degradation, indicating
that both pharmaceuticals are mainly decomposed by the attack of
OH radicals at the interface of collapsing bubbles. However 5% of
degradation was reached for paracetamol and 17% for levodopa,
suggesting that some minor degradation can also take place in
the bulk solution. Because paracetamol has a higher log POW than
levodopa, one could expect that its degradation at the interface will
reach a higher extend than levodopa and thus that the influence of
1-butanol will be also higher. For levodopa, due to its higher
hydrophilicity (log POW = ÿ2.92), the mechanism in the bulk solu-
tion is more important than for paracetamol. On the other hand,
the thermal decomposition of levodopa at the gas–liquid interface
cannot be neglected because in recent studies developed in our
laboratory, the thermal decomposition of levodopa was observed
for temperatures between 120 and 150 °C under inert atmosphere.
Then, the differences observed in the degradation mechanisms of
the two products could be linked to the difference in physical
and chemical properties of the molecules (Table 1).
3.5. Sonochemical degradation with hydrogen peroxide
Additional experiments were carried out in order to study the
benefits, if any, of using ultrasound in conjunction with an oxidant
such as H2O2 at various initial concentrations. The reference H2O2
concentration corresponds to the stoichiometric amount of the
oxidant needed for the complete oxidation of 25 mg Lÿ1 of the
pharmaceutical aqueous solution (95 mg Lÿ1 for levodopa
and 106 mg Lÿ1 for paracetamol) according to the following
reactions:
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Fig. 5. Effect of n-butanol on levodopa and paracetamol sonochemical degradation. (frequency: 574 kHz, actual power: 32 W, pollutant initial concentration: 25 mg Lÿ1).
( ) Levodopa without scavenger, ( ) Levodopa with n-butanol, ( ) paracetamol without scavenger, ( ) paracetamol with n-butanol.
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Fig. 4. Influence of ultrasonic actual power on levodopa ( ) and paracetamol ( )
removal after 240 min of sonolysis (frequency: 574 kHz, pollutant initial concen-
tration: 25 mg Lÿ1 temperature: 20 °C).
C9H11NO4 þ 22H2O2 ! 9CO2 þ 27H2OþHNO3 ð2Þ
C8H9NO2 þ 21H2O2 ! 8CO2 þ 25H2OþHNO3 ð3Þ
For a better understanding of the H2O2 influence, smaller and
higher concentrations than stoichiometry were used. The results
of this study at 574 kHz, 20 oC, 32 W of actual power and initial sol-
ute concentrations of 25mg Lÿ1 are shown in Fig. 6. For comparison,
the degradation of the two pharmaceuticals in identical conditions
but without sonication, was also studied (data not shown). No pol-
lutant degradation was observed in silent conditions.
In the case of levodopa, the initial degradation rate increases
slightly up to an H2O2 concentration of 948 mg L
ÿ1 (10 fold stoichi-
ometric), beyond which it decreases. Paracetamol shows a dra-
matic dependence on the hydrogen peroxide concentration
present in the reaction medium (initial rate can be multiplied by
6). Similarly to levodopa, there is an optimum for the H2O2 concen-
tration used. Initial degradation rate increases up to an H2O2 con-
centration of 590 mg Lÿ1 (5 fold stoichiometric) beyond which it
decreases. However, the position of these maxima is not very accu-
rate, due to the low number of H2O2 concentration values.
In general, H2O2 is expected to promote degradation since it
may be decomposed by ultrasound to reactive hydroxyl radicals,
thus promoting pollutant degradation. Several authors published
the positive influence of H2O2 in organic pollutants sonodegrada-
tion [34,42,10]. On the other hand, Manousaki et al. [25] found a
detrimental effect of H2O2 on sodium dodecylbenzene sulfonate
sonochemical degradation and Velegraki et al. [43], who studied
the effect of H2O2 concentration (0–1050 mg L
ÿ1) on acid orange
7 photocatalytic oxidation, found that degradation is impeded for
the whole range of H2O2 concentration studied. They argued that,
depending on the reaction conditions and on the system in ques-
tion, there is an optimum H2O2 concentration, above which H2O2
acts as a radical scavenger, thus leading to reduced degradation.
It is important to note that such an effect would probably be more
marked in the solution bulk, where the reaction with the substrate
is the main removal process for OH, than at the air–water interface
where the recombination of OH + OH would strongly predominate.
The difference in the optimum concentrations of H2O2 could be due
to the difference in degradation sites (interface vs. bulk) of both
products (see Section 3.4), but also to the presumably different
reaction rate constants of the substrates.
Gogate [13] affirms that the effect of the combined ultrasound
plus H2O2 process will be very much dependent on the utilization
of free radicals by the pollutant molecules, which in turn is depen-
dent on the efficiency of contact of the generated free radicals with
the pollutant over a specified time period. Our results suggest that
effectively levodopa and paracetamol degradation mechanisms are
different, and thus optimum H2O2 concentration values depend on
the nature of pollutants.
4. Conclusions
High frequency ultrasound can promote the oxidation of levo-
dopa and paracetamol in relatively dilute synthetic solutions and
the extent of degradation strongly depends on the operating condi-
tions. Ultrasonic treatment alone may not be suitable for decon-
taminating completely levodopa and paracetamol solutions.
However, process efficiency may be improved by coupling with
biological treatment, which will carry on mineralization as far as
possible.
Hydroxyl radical-mediated reactions occurring at the gas–liquid
interface appear to be the prevailing degradation mechanism. The
use of an extra oxidant like H2O2 for enhancing the extent of deg-
radation is possible but the use of the adequate concentration is an
important parameter because H2O2 can act as a radical promoter or
scavenger, depending on the product and the conditions used.
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